Deciphera Pharmaceuticals, Inc. stock is up 1.26% since 30 days ago. The next earnings date is Feb 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 71.43% of the previous 6 November’s closed higher than October. In the last 2 Unusual Options Trades, there were 2 CALLs. 80% of analysts rate it a buy.
Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST)